[PGAM5 deficiency attenuates atherosclerosis, enhances oxidized LDL uptake by liver sinusoidal endothelial cells and reshapes circulating lipidome in mice]. [PDF]
Tan H +6 more
europepmc +1 more source
[Correlation between trimethylamine-N-oxide and cardiovascular metabolic markers]. [PDF]
Zhang H +18 more
europepmc +1 more source
[Exploration of the mechanisms of portal hypertension driven by metabolic disorders in non-cirrhotic stages of metabolic-associated fatty liver disease]. [PDF]
Zhao YQ, Wang Y, Liu JJ, You H, Zhao JJ.
europepmc +1 more source
本研究使用大豆蛋白、鈣等材料,設計一大豆蛋白複合配方作為樣品,在倉鼠模式下探討樣品調節血脂之能力,將倉鼠分成5組,餵予普通飼料(C)、高脂飼料(HF) (含14%油脂、0.2%膽固醇)及添加低(0.5X)、中(1X)及高(2X)劑量樣品之高脂飼料共8週。 實驗結果顯示,相較於高脂飼料組(HF),中劑量(1X)與高劑量(2X)組可顯著(p < 0.05)降低血清三酸甘油酯濃度約22-24%,血清總膽固醇濃度下降約15-22%,血清低密度脂蛋白膽固醇濃度減少約26-37%,此外,與高脂控制組(HF)相比 ...
Zhi-Yi Yu, 余芝儀
core
[CEBPA promotes hepatic steatosis in metabolic dysfunction-associated fatty liver disease in mice <i>via</i> the SREBP-1c/FASN/ACC axis]. [PDF]
Zhang L +7 more
europepmc +1 more source
[Schisandrin A alleviates neuronal ferroptosis in mice with hypoxic-ischemic brain injury by inhibiting the ACSL4/TFRC/PTGS2 signaling pathway]. [PDF]
Guo T +8 more
europepmc +1 more source
[Proportion and clinical characteristics of probable metabolic-associated fatty liver disease-related cirrhosis in cryptogenic cirrhosis]. [PDF]
Wang Y +7 more
europepmc +1 more source
[Aerobic exercise improves metabolic disorders and multi-organ damage in diabetic rats by activating the Sirt1/Creb1/Ppargc1a axis]. [PDF]
Zhang G, Li X, Mi Y, Tian D, Meng J.
europepmc +1 more source
[Across-sectional study on the association between steatotic liver disease and its subtypes, cardiovascular health status, and extrahepatic comorbidity]. [PDF]
Guan JB +8 more
europepmc +1 more source
[Noninvasive scores for predicting liver-related events in patients with metabolic dysfunction-associated fatty liver disease]. [PDF]
Gao YK +6 more
europepmc +1 more source

